Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v3-FR
Language English French
Date Updated 2019-03-29 2019-03-20
Drug Identification Number 02249472 02249472
Brand name PREVACID FASTAB PREVACID FASTAB
Common or Proper name LANSOPRAZOLE LANSOPRAZOLE
Company Name TAKEDA PHARMACEUTICALS AMERICA INC TAKEDA PHARMACEUTICALS AMERICA INC
Ingredients LANSOPRAZOLE LANSOPRAZOLE
Strength(s) 30MG 30MG
Dosage form(s) TABLET (DELAYED-RELEASE) TABLET (DELAYED-RELEASE)
Route of administration ORAL ORAL
Packaging size 3 x 10, 10 x 10 3 x 10, 10 x 10
ATC code A02BC A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2019-03-20 2019-03-20
Actual start date
Estimated end date 2019-03-29
Actual end date 2019-03-28
Shortage status Resolved Anticipated shortage
Company comments
Health Canada comments